Application 077661
- Type
- ANDA
- Sponsor
- RUBICON
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 004 | GABAPENTIN | GABAPENTIN | TABLET;ORAL | 600MG | No | No |
| 005 | GABAPENTIN | GABAPENTIN | TABLET;ORAL | 800MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 60505-2551 | Gabapentin | Gabapentin | Apotex Corp. | ANDA | Current |
| 60505-2551 | Gabapentin | Gabapentin | Apotex Corp. | ANDA | Current |
| 60505-2551 | Gabapentin | Gabapentin | Apotex Corp. | ANDA | Current |
| 60505-2552 | Gabapentin | Gabapentin | Apotex Corp. | ANDA | Current |
| 60505-2552 | Gabapentin | Gabapentin | Apotex Corp. | ANDA | Current |
| 60505-2552 | Gabapentin | Gabapentin | Apotex Corp. | ANDA | Current |
| 60505-2552 | Gabapentin | Gabapentin | Apotex Corp. | ANDA | Current |
| 60505-2552 | Gabapentin | Gabapentin | Apotex Corp. | ANDA | Current |
| 68071-3244 | Gabapentin | Gabapentin | NuCare Pharmaceuticals, Inc. | ANDA | Current |
| 72888-131 | Gabapentin | gabapentin | Advagen Pharma Ltd | ANDA | Current |
| 72888-132 | Gabapentin | gabapentin | Advagen Pharma Ltd | ANDA | Current |